+44 (0)114 215 9667 mellanbycentre@sheffield.ac.uk


Professor Richard Eastell


Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings SR, Eastell (2019)  The risk of hip and non-vertebral fractures in patients with Parkinson’s disease and parkinsonism: A systematic review and meta-analysis. Bone. Nov 29;132:115173. doi: 10.1016/j.bone.2019.115173. [Epub ahead of print] PubMed PMID: 31790846.

Gossiel F, Paggiosi MA, Naylor KE, McCloskey EV, Walsh J, Peel N, Eastell R. (2019)  The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: The T-score bone marker approach in the TRIO study. Bone. Nov 15;131:115158. doi:  10.1016/j.bone.2019.115158. [Epub ahead of print] PubMed PMID: 31740343.

Zarecki P, Hackl M, Grillari J, Debono M, Eastell R. (2019)  Serum microRNAs as novel biomarkers for osteoporotic vertebral fractures. Bone. 2020 Jan;130:115105. doi: 10.1016/j.bone.2019.115105. Epub 2019 Oct 24. PubMed PMID: 31669252.

Farzi M, Pozo JM, McCloskey E, Eastell R, Harvey N, Wilkinson JM, Frangi AF. A (2019)  Spatio-Temporal Ageing Atlas of the Proximal Femur. IEEE Trans Med Imaging. Oct 23. doi: 10.1109/TMI.2019.2945219. [Epub ahead of print] PubMed PMID: 31647421.

Shapiro CL, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R, Smith S, Edwards BJ, Frank E, Lyman GH, Smith MR, Mhaskar R, Henderson T, Neuner J. (2019)  Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. J Clin Oncol. Nov 1;37(31):2916-2946. doi: 10.1200/JCO.19.01696. Epub 2019 Sep 18. PubMed PMID: 31532726.

Tsai JN, Lee H, David NL, Eastell R, Leder BZ. (2019)  Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. Lancet Diabetes Endocrinol. Oct;7(10):767-775. doi: 10.1016/S2213-8587(19)30255-4. Epub Aug 22. PubMed PMID: 31447409.

Cummings SR, Lui LY, Eastell R, Allen IE. (2019)  Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates: A Meta-analysis. JAMA Intern Med. Aug 19. doi: 10.1001/jamainternmed.2019.2779. [Epub ahead of print] PubMed PMID: 31424486; PubMed Central PMCID: PMC6704731.

Hill TR, Verlaan S, Biesheuvel E, Eastell R, Bauer JM, Bautmans I, Brandt K, Donini LM, Maggio M, Mets T, Seal CJ, Wijers SL, Sieber C, Cederholm T, Aspray TJ (2019)  PROVIDE Consortium. A Vitamin D, Calcium and Leucine-Enriched Whey Protein Nutritional Supplement Improves Measures of Bone Health in Sarcopenic Non-Malnourished Older Adults: The PROVIDE Study. Calcif Tissue Int. Oct;105(4):383-391. doi: 10.1007/s00223-019-00581-6. Epub 2019 Jul 23. PubMed PMID: 31338563. 

Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Zhang L, Theodore-Oklota C, Mealiffe M, San Martin J, Insogna K. (2019)  Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period. Calcif Tissue Int. Sep;105(3):271-284. doi: 10.1007/s00223-019-00568-3. Epub 2019 Jun 4. PubMed PMID: 31165191.

Cavalier E, Eastell R, Rye Jørgensen N, Makris K, Tournis S, Vasikaran S, Kanis JA, Cooper C, Pottel H, Morris HA; IFCC-IOF Joint Committee for Bone Metabolism (C-M). (2019)  A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism. Clin Chem Lab Med. Sep 25;57(10):1546-1555. doi: 10.1515/cclm-2019-0174. PubMed PMID: 31085740.

Sestak I, Blake GM, Patel R, Coleman RE, Cuzick J, Eastell R. (2019)  Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia. Bone. Jul;124:83-88. doi: 10.1016/j.bone.2019.04.016. Epub Apr 24. PubMed PMID: 31028957; PubMed Central PMCID: PMC6548284.

Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. (2019)  Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221. PubMed PMID: 30907953.  

Ebeling PR, Akesson K, Bauer DC, Buchbinder R, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D, Katzman W, Rodriguez A, Wermers R, Wilson HA, Bouxsein ML. (2019)  The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report. J Bone Miner Res. Jan;34(1):3-21. doi: 10.1002/jbmr.3653. PubMed PMID: 30677181.

Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM; FNIH Bone Quality Project. (2019)  Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials. J Bone Miner Res. Apr;34(4):632-642. doi: 10.1002/jbmr.3641. Epub 2019 Jan 23. PubMed PMID: 30674078.

Eastell R, Mitlak BH, Wang Y, Hu M, Fitzpatrick LA, Black DM. (2019)  Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE. Osteoporos Int. Mar;30(3):667-673. doi: 10.1007/s00198-018-04819-1. Epub 2019 Jan 11. PubMed PMID: 30635696; PubMed Central PMCID: PMC6422956.

Naylor KE, McCloskey EV, Jacques RM, Peel NFA, Paggiosi MA, Gossiel F, Walsh JS, Eastell R. (2019)  Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis. Osteoporos Int. 2019 Apr;30(4):917-922. doi: 10.1007/s00198-018-04823-5. Epub Jan 6. PubMed PMID: 30613868.

Kim TY, Bauer DC, McNabb BL, Schafer AL, Cosman F, Black DM, Eastell R. (2019)  Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials. J Bone Miner Res. May;34(5):810-816. doi: 10.1002/jbmr.3654. Epub 2019 Jan 15.  PubMed PMID: 30536713.

Vilaca T, Walsh J, Eastell R. (2019)  Discordant pattern of peripheral fractures in diabetes: a meta-analysis on the risk of wrist and ankle fractures. Osteoporos Int. Jan;30(1):135-143. doi: 10.1007/s00198-018-4717-0. Epub 2018 Oct 10. PubMed PMID: 30306223.

Gopal-Kothandapani JS, Evans LF, Walsh JS, Gossiel F, Rigby AS, Eastell R, Bishop NJ. (2019)  Effect of vitamin D supplementation on free and total vitamin D: A comparison of Asians and Caucasians. Clin Endocrinol (Oxf). Jan;90(1):222-231. doi: 10.1111/cen.13825. Epub 2018 Sep 9. PubMed PMID: 30067874.

Eastell, R., Dijk, D.J., Small, M., Greenwood, A., Sharpe, J., Yamada, H., Yuba, M., Tanimoto, M. & Deacon, S. (2015) Morning vs evening dosing of the cathepsin K inhibitor ONO-533: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial. Osteoporos Int. Oct 7. [Epub ahead of print] PubMed PMID: 26446770

Blum, M.R., Bauer, D.C., Collet, T.H., Fink, H.A., Cappola, A.R., da Costa, B.R., Wirth, C.D., Peeters, R.P., Åsvold, B.O., den Elzen, W.P., Luben, R.N., Imaizumi, M., Bremner, A.P., Gogakos, A., Eastell, R., Kearney, P.M., Strotmeyer, E.S., Wallace, E.R., Hoff, M., Ceresini, G., Rivadeneira, F., Uitterlinden, A.G., Stott, D.J., Westendorp, R.G., Khaw, K.T., Langhammer, A., Ferrucci, L., Gussekloo, J., Williams, G.R., Walsh, J.P., Jüni, P., Aujesky, D., Rodondi, N. (2015) Thyroid Studies Collaboration. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 26;313(20):2055-65. doi: 10.1001/jama.2015.5161.
PubMed PMID: 26010634

Naylor, K.E., Jacques, R.M., Paggiosi, M., Gossiel, F., Peel, N.F., McCloskey, E.V., Walsh, J.S., Eastell, R. (2015) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int May 20. [Epub ahead of print] PubMed PMID: 25990354

Paggiosi, M.A., Peel, N.F., Eastell, R. (2015) The impact of glucocorticoid therapy on trabecular bone score in older women. Osteoporos Int Jun;26(6):1773-80 doi: 10.1007/s00198-015-3078-1. Epub 2015 Mar 6. PubMed PMID: 25743176

Palermo, A., Jacques, R., Gossiel, F., Reid, D.M., Roux, C., Felsenberg, D., Glueer, C.C., Eastell, R. (2015) Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study. Clin Endocrinol (Oxf. Jun;82(6):816-23. doi: 10.1111/cen.12732. Epub 2015 Feb 23. PubMed PMID: 25640980

Black, D.M., Reid, I.R., Cauley, J.A., Cosman, F., Leung, P.C., Lakatos, P., Lippuner, K., Cummings, S.R., Hue, T.F., Mukhopadhyay, A., Tan, M., Aftring, R.P., Eastell, R. (2015) The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res May;30(5):934-44. doi: 10.1002/jbmr.2442. PubMed PMID: 25545380

Dimitri, P., Jacques, R.M., Paggiosi, M., King, D., Walsh, J., Taylor, Z.A., Frangi, A.F., Bishop, N., Eastell, R. (2015) Leptin may play a role in bone microstructural alterations in obese children. J Clin Endocrinol Metab Feb;100(2):594-602. doi:10.1210/jc.2014-3199. Epub 2014 Nov 20. PubMed PMID: 25412414; PubMed Central PMCID: PMC4318898

Evans, A.L., Paggiosi, M.A., Eastell, R., Walsh, J.S. (2015) Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res May;30(5):920-8. doi: 10.1002/jbmr.2407. PubMed PMID: 25400253

Eastell, R., Boonen, S., Cosman, F., Reid, I.R., Palermo, L., Cummings, S.R., Black, D.M. (2015) Relationship between pre-treatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study. J Bone Miner Res Mar;30(3):570-4. doi: 10.1002/jbmr.2361. PubMed PMID: 25214069

Palermo, A., D’Onofrio, L., Eastell, R., Schwartz, A.V., Pozzilli, P., Napoli, N. (2015) Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporos Int Aug;26(8):2073-89. doi: 10.1007/s00198-015-3123-0. Epub 2015 Apr 25. PubMed PMID: 25910746